Critical Comparison: InterCure (NASDAQ:INCR) vs. GlucoTrack (NASDAQ:GCTK)

InterCure (NASDAQ:INCR) and GlucoTrack (NASDAQ:GCTK) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, dividends, earnings and profitability.

Earnings and Valuation

This table compares InterCure and GlucoTrack”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InterCure	$64.55 million	N/A	-$18.32 million	$0.03	29.97
GlucoTrack	N/A	N/A	-$19.39 million	($55.51)	-0.01

InterCure has higher revenue and earnings than GlucoTrack. GlucoTrack is trading at a lower price-to-earnings ratio than InterCure, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares InterCure and GlucoTrack’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
InterCure	N/A	N/A	N/A
GlucoTrack	N/A	-324.84%	-178.16%

Analyst Ratings

This is a breakdown of recent ratings for InterCure and GlucoTrack, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InterCure	1	0	0	0	1.00
GlucoTrack	1	0	0	0	1.00

Institutional and Insider Ownership

8.3% of InterCure shares are held by institutional investors. Comparatively, 10.9% of GlucoTrack shares are held by institutional investors. 0.2% of InterCure shares are held by insiders. Comparatively, 2.2% of GlucoTrack shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

InterCure has a beta of 1.22, meaning that its share price is 22% more volatile than the S&P 500. Comparatively, GlucoTrack has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500.

Summary

InterCure beats GlucoTrack on 7 of the 9 factors compared between the two stocks.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

About GlucoTrack

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.